Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atopic dermatitis
Marketing
New treatments needed in chronic hand eczema: GlobalData
The lack of approved treatments that manage inflammation without major side effects has created a significant gap in the chronic hand eczema space.
Andrea Park
Dec 19, 2024 3:35pm
Organon's Vtama, Galderma's Nemluvio endorsed by FDA for eczema
Dec 16, 2024 9:00am
Nektar extends cash runway with $90M manufacturing plant sale
Nov 4, 2024 1:16pm
J&J's Tremya, Lilly's Ebglyss score in new patient groups
Oct 25, 2024 11:00am
Incyte picks Dr. Pimple Popper to expand Opzelura campaign
Oct 14, 2024 10:23am
Organon pays up to $1.2B to acquire Dermavant and its drug Vtama
Sep 18, 2024 10:09am